Pradžia › Krūties vėžys › Rhode Island
Krūties vėžys klinikiniai tyrimai Rhode Island
14 tyrimai dėl Krūties vėžys ieško dalyvių vietose Rhode Island.
Miestai Rhode Island
Oficialus tyrimo tekstas (anglų kalba)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Rhode Island Hospital, Providence
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kent Hospital, Warwick
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Smilow Cancer Hospital - Westerly, Westerly
Renkami dalyviai3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06377852A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Providence
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06103864A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Rhode Island Hospital, Providence
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06492616Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Women and Infants Hospital, Providence
- Kent Hospital, Warwick
- Smilow Cancer Hospital Care Center - Westerly, Westerly
Renkami dalyviai3 fazė
Amžius nuo 18 iki 60 · Moterims · Atnaujinta 2026-09-02 · NCT05879926ATEMPT 2.0: Adjuvant T-DM1 vs TH
- Smilow Cancer Hospital Care center at Westerly, Westerly
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT04893109Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Women and Infants Hospital of Rhode Island, Providence
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-04 · NCT05579366E-Mindfulness Approaches for Living After Breast Cancer
- Women and Infants Hospital, Providence
Renkami dalyviai3 fazė
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06748222A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Rhode Island Hospital, Providence
- Women and Infants Hospital, Providence
- Kent Hospital, Warwick
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 50 iki 70 · Visoms lytims · Atnaujinta 2026-04-23 · NCT04852887EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Women & Infants Hospital, Providence
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-20 · NCT06401421SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Providence
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-24 · NCT06974604Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.